VIVIAN CHARNECO: Open Payments
NPI 1144322025 · KISSIMMEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,031 in 82 payments from 11 companies in 2025. Trend: 2023 $2,524 · 2024 $2,425 · 2025 $2,031
Food & beverage: $2,031
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $443 |
| E.R. Squibb & Sons, L.L.C. | 6 | $316 |
| Axsome Therapeutics, Inc. | 5 | $305 |
| Janssen Pharmaceuticals, Inc | 11 | $235 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $223 |
| Neurocrine BioSciences, Inc. | 4 | $198 |
| Alkermes, Inc. | 8 | $143 |
| Otsuka America Pharmaceutical, Inc. | 5 | $102 |
| Tris Pharma Inc | 2 | $35 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
Products named: VRAYLAR, COBENFY, Auvelity, CAPLYTA, INGREZZA, SPRAVATO, ARISTADA, INVEGA SUSTENNA.
Industry payments across FL — which companies pay providers there.
